Edition:
United States

ImmunoGen Inc (IMGN.OQ)

IMGN.OQ on NASDAQ Stock Exchange Global Select Market

5.70USD
20 Nov 2017
Change (% chg)

-- (--)
Prev Close
$5.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
796,817
52-wk High
$8.84
52-wk Low
$1.53

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.09 December 21 Nov 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 1 1 1 1
(3) HOLD 3 3 3 3
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.11 2.11 2.11 2.11

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 8 35.72 42.60 8.40 --
Quarter Ending Mar-18 4 14.11 19.75 5.70 --
Year Ending Dec-17 9 116.80 155.45 84.59 --
Year Ending Dec-18 9 59.49 94.74 13.00 --
Earnings (per share)
Quarter Ending Dec-17 8 -0.09 -0.06 -0.13 --
Quarter Ending Mar-18 4 -0.26 -0.20 -0.34 --
Year Ending Dec-17 8 -1.01 -0.93 -1.27 --
Year Ending Dec-18 9 -1.16 -0.78 -1.69 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 33.62 8.48 25.14 74.78
Quarter Ending Jun-17 30.59 39.02 8.43 27.57
Quarter Ending Mar-17 16.16 28.69 12.53 77.55
Quarter Ending Jun-16 17.11 7.41 9.70 56.70
Quarter Ending Mar-16 23.17 19.71 3.46 14.92
Earnings (per share)
Quarter Ending Sep-17 -0.19 -0.61 0.42 -217.38
Quarter Ending Jun-17 -0.16 -0.14 0.02 -14.84
Quarter Ending Mar-17 -0.34 -0.20 0.14 -41.61
Quarter Ending Jun-16 -0.39 -0.51 0.12 -30.33
Quarter Ending Mar-16 -0.31 -0.37 0.06 -17.68

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 35.72 35.73 27.10 27.10 --
Quarter Ending Mar-18 14.11 14.10 12.53 12.53 --
Year Ending Dec-17 116.80 116.80 131.80 129.04 --
Year Ending Dec-18 59.49 59.49 63.10 60.32 --
Earnings (per share)
Quarter Ending Dec-17 -0.09 -0.09 -0.24 -0.24 --
Quarter Ending Mar-18 -0.26 -0.26 -0.41 -0.41 --
Year Ending Dec-17 -1.01 -1.01 -0.72 -0.74 --
Year Ending Dec-18 -1.16 -1.16 -1.39 -1.53 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 1 6 2
Quarter Ending Mar-18 1 0 1 1
Year Ending Dec-17 0 0 1 8
Year Ending Dec-18 0 0 3 2
Earnings
Quarter Ending Dec-17 0 0 7 1
Quarter Ending Mar-18 0 0 2 0
Year Ending Dec-17 0 0 0 8
Year Ending Dec-18 0 0 7 1